The impact of whole genome sequence data on drug discovery - A malaria case study

Molecular Medicine

Volumn 7, Issue 10, 2001, Pages 698-710

  Joachimiak, M P ^a   Chang, C ^a   Rosenthal, P J ^a   Cohen, F E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; EPOXIDE; FALCIPAIN 2; FALCIPAIN 3; HEMOGLOBIN HYDROXYLASE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG DESIGN; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ERYTHROCYTE; GENE SEQUENCE; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; TROPHOZOITE;

ANIMALS; ANTIMALARIALS; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA, PROTOZOAN; DRUG DESIGN; ERYTHROCYTES; HUMANS; PLASMODIUM FALCIPARUM;

EID: 0035163181     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Stroke: Development, prevention and treatment with peptidase inhibitors
2. Nelfinavir mesylate
3. Is there a future for renin inhibitors?
4. Identification of three stage-specific proteinases of Plasmodium falciparum
5. Isolation and characterization of a cysteine protease gene of Plasmodium falciparum
6. Structure-based inhibitor design by using protein models for the development of antiparasitic agents
7. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum
8. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum
9. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase
10. High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparum
11. Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton
12. Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum
13. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine protease
14. Antimalarial effects of vinyl sulfone cysteine protease inhibitors
15. Anti-malarial drug development using models of enzyme structure
16. Structure-based design of parasitic protease inhibitors
17. A surface of minimum area metric for the structural comparison of proteins
18. Chimera: An extensible molecular modeling application constructed using standard components
19. On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain
20. WebMol - A Java based PDB viewer
21. The lysosomal cysteine proteases
22. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
23. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: Biological and clinical implications
24. Gastrointestinal stromal tumors
25. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
26. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification
27. Revised definition of the substrate binding sites of papain-like cysteine proteases
28. An evolutionary trace method defines binding surfaces common to protein families
29. Fast and robust computation of molecular surfaces
30. Co-evolution of proteins with their interaction partners
31. Reduced surface: An efficient way to compute molecular surfaces
32. Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P
33. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
34. Evaluation of comparative protein structure modeling by MODELLER-3
35. Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: A new homology modeling tool
36. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
37. Performance evaluation of amino acid substitution matrices
38. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
39. Synchronization of Plasmodium falciparum erythrocytic stages in culture